When it comes to taking medication, everyone knows the importance of adhering to the prescribed course of treatment. At least that's the theory. According to the WHO, however, only half of all patients comply with their doctors' instructions. This unsatisfactory rate prompted Sanner GmbH and digital health startup Amiko to examine how artificial intelligence (AI), drug delivery systems and add-ons can help ensure medication is taken correctly. By combining Sanner’s years of experience in manufacturing customized pharmaceutical packaging, dosing and delivery systems with Amiko's advanced sensor technology, the two companies are focusing their energies on developing effective new solutions for treating respiratory diseases and other chronic conditions.
The starting point for the partnership was a strategic investment by Sanner Ventures GmbH in enhancing Amiko’s Respiro Platform, an innovative respiratory disease management tool. The partnership now also has an operational dimension to integrate Amiko's patented sensor technology into customer-specific add-ons and new medical products for pharmaceutical customers. "Sanner has extensive expertise in developing and manufacturing drug delivery systems, customized primary packaging and moisture protection solutions," says Dirk Mähr, the company's Managing Director. "Together with Amiko's digital Respiro Platform and unique sensor technology, we're harnessing these synergies to develop smart solutions for true medication adherence in treating respiratory diseases."
Sanner Ventures GmbH (64625 Bensheim, Germany)